original ) (raw )Role of anti-GAD, anti-IA2 antibodies and C-peptide in differentiating latent autoimmune diabetes in adults from type 2 diabetes mellitus
Sujesh Kumar
International Journal of Diabetes in Developing Countries, 2015
View PDFchevron_right
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry
Leonard Kaufman
Diabetes Care, 2000
View PDFchevron_right
Type 1 diabetes in insulin-treated adult-onset diabetic subjects
Ian Mackay
Diabetes Research and Clinical Practice, 1998
View PDFchevron_right
Clinical phenotype and -cell autoimmunity in Italian patients with adult-onset diabetes
P. Travaglini
European Journal of Endocrinology, 2006
View PDFchevron_right
Diabetes-related antibodies in adult diabetic patients
Alberto Falorni
Best Practice & Research Clinical Endocrinology & Metabolism, 2005
View PDFchevron_right
Changes in GAD65Ab-Specific Antiidiotypic Antibody Levels Correlate with Changes in C-Peptide Levels and Progression to Islet Cell Autoimmunity
B. Brooks-worrell
The Journal of Clinical Endocrinology & Metabolism, 2010
View PDFchevron_right
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
Anita Ramelius
Diabetes, 1999
View PDFchevron_right
Islet cell autoantibody levels after the diagnosis of young adult diabetic patients
Kristian Lynch
Diabetic Medicine, 2007
View PDFchevron_right
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes
J. Schepper , H. Dorchy , L. Van Gaal
Diabetologia, 2006
View PDFchevron_right
Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus - a nationwide study
Jan Bolinder
Diabetic Medicine, 2000
View PDFchevron_right
The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study
Ruth Weinstock
Diabetes Care, 2010
View PDFchevron_right
Identifying latent autoimmune diabetes in adults in Korea: The role of C-peptide and metabolic syndrome
Bong-yun Cha
Diabetes Research and Clinical Practice, 2009
View PDFchevron_right
The natural history of pre-Type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases
Ljiljana Moro
Diabetologia, 1994
View PDFchevron_right
Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain
Joan Verdaguer
Diabetes/Metabolism Research and Reviews, 2013
View PDFchevron_right
High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry
Luc Van Gaal
Diabetes Care, 2000
View PDFchevron_right
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds
Jan Bolinder
Diabetes/Metabolism Research and Reviews, 2000
View PDFchevron_right
Latent autoimmune diabetes in adults in a population-based cohort of Polish patients with newly diagnosed diabetes mellitus
Maria Gorska
Archives of Medical Science, 2012
View PDFchevron_right
Gender differences in GAD antibody– positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases
Bengt Hallengren
Diabetes/Metabolism Research and Reviews, 2004
View PDFchevron_right
Genetic Markers, Serological Auto Antibodies and Prediction of Type 1 Diabetes
raouia fakhfakh
Type 1 Diabetes - Pathogenesis, Genetics and Immunotherapy, 2011
View PDFchevron_right
Factors associated with preservation of C-peptide levels at the diagnosis of type 1 diabetes
Artur Bossowski
Journal of Diabetes and its Complications, 2018
View PDFchevron_right
Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians
Abhishek Singh
Diabetic Medicine, 2000
View PDFchevron_right
Combined Measurement of Diabetes Mellitus Immunological Markers: an Assessment of its Benefits in Adult-Onset Patients
Vivian Labovsky
Autoimmunity, 2001
View PDFchevron_right
33. ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
Lejla Zunic
Acta Informatica Medica, 2016
View PDFchevron_right
Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes
Akinori Kimura
Diabetes Research and Clinical Practice, 2004
View PDFchevron_right
Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): Absence of rapid beta-cell loss in patients with tight metabolic control
L. Chaillous
Diabetes & Metabolism, 2010
View PDFchevron_right
Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based study
R. Buzzetti
Metabolism, 1998
View PDFchevron_right
Prognostic Factors for the Course of β Cell Function in Autoimmune Diabetes1
Bengt Littorin
The Journal of Clinical Endocrinology & Metabolism, 2000
View PDFchevron_right
Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients
Åke Lernmark
Diabetologia, 1985
View PDFchevron_right